| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | In conclusion, CXCL10 is an important marker of HCV clearance and successful therapy in CHC patients. | 31485460 | 2019 | ||||
|
0.080 | Biomarker | disease | BEFREE | OCI patients had higher alanine aminotransferase normalization rates after Peg-interferon treatment than CHC patients (P < 0.05) and serum CXCL10 decreased significantly (P < 0.0001). | 29853737 | 2018 | ||||
|
0.080 | GeneticVariation | disease | BEFREE | Here we recruited chronic hepatitis C (CHC) patients to perform an association study between three single nucleotide polymorphisms (SNPs) (CXCR2 rs1126579, CXCL10 rs8878 and CXCL10 rs3921) and HCV infection outcomes and treatment responses among a Chinese population, using primarily a TaqMan assay. | 29948377 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | One of the multiple factors contributing to virological response in chronic hepatitis C (CHC) is interferon-gamma-inducible protein-10 (IP-10). | 28862188 | 2017 | ||||
|
0.080 | GeneticVariation | disease | BEFREE | This study aimed to determine the association between genetic variations of CXCL10 and DPP4 and the outcome of treatment with pegylated interferon-α (PEG-IFN-α) based therapy in Thai patients with CHC. | 26339796 | 2015 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | We determined IP-10 serum levels in Chinese CHC patients undergoing PEG-IFN-based therapy. | 25263691 | 2014 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | To determine the independent contribution of factors including IL28B polymorphisms, IFN-gamma inducible protein-10 (IP-10) levels and the homeostasis model assessment of insulin resistance (HOMA-IR) score in predicting response to therapy in chronic hepatitis C (CHC). | 21443535 | 2011 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Increased serum and intrahepatic interferon gamma inducible protein 10 (IP-10) levels in patients with chronic hepatitis C (CHC) have been described. | 16150856 | 2006 |